Skip to content

AIM round-up: Harland & Wolff, Quantum Blockchain, Jadestone Energy


London’s AIM Index spent Wednesday’s session in positive territory but failed to make any meaningful progress, finishing the day just under a point higher at 859.10, although comfortably outperforming the senior market.

  • Harland & Wolff +26%
  • Quantum Blockchain +18%
  • Jadestone Energy +12%
  • IOG -54%
  • Blue Rock Diamonds -25%

Harland & Wolff [LON:HARL] was the best performer on Wednesday, settling some 26% higher. Price action kicked in first thing but it was the confirmation of a contract being signed with the MoD at 1pm that gave the stock a true shot in the arm. Questions may be asked over whether the RNS should have been issued earlier in the day…

Quantum Blockchain [LON:QBT] was in second place, up 18% at the bell. The stock has been buoyed of late by some renewed confidence over the crypto outlook but this morning news from management that the company was now pursing AltCoin opportunities provided another leg up. Interest in the stock was elevated although the closing spread accounted for around half of the upside.

Jadestone Energy [LON:JSE] gets the day’s notable mention, advancing 12% and seemingly helped along by this morning’s corporate update. The tone was certainly positive and increased interest was seen on the stock, but locking in these gains without further meaningful updates may still prove challenging.

IOG [LON:IOG] was the day’s laggard, finishing some 54% down. An update on the company’s Southwark project showed a low gas rate and apparent water formation, which management described as “disappointing” with testing falling short of expectations. Investors were clearly quick to latch onto this.

Blue Rock Diamonds [LON:BRD] slipped 25% by the close, with the company’s stock extending yesterday’s losses off the back of its operational update. Trade was however very thin and there seem to be few advocates around for the stock right now, reflected in the wide closing spread.

Like this article? Sign up to our free newsletter.

This article does not constitute investment advice. Do your own research or consult a professional advisor.

'How to' Guides

Our latest in-depth company reports

Detailed reviews of selected companies and investment trusts.

On the podcast

Sign up for great investing stock tips

Thanks to our Partners

Our partners are established, regulated businesses and we are grateful for their support.

FP Markets
CME Group
Back To Top